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Abstract 
Review on Renal cell carcinoma with 
inv(X)(p11q12) NONO/TFE3, with data on clinics, 
and the genes involved. 
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Identity 
Other names 
NONO-TFE3 renal cell carcinoma 
Classification 
This renal cell carcinoma belongs to the family of 
Xp11 translocation renal carcinomas. Xp11 
translocation renal cell carcinomas (RCCs) harbor 
gene fusions involving TFE3 transcription factor. 
The t(6;11) RCCs harbor a specific MALAT1 
(Alpha) - TFEB gene fusion. TFEB and TFE3 
belong to the same MiT subfamily of transcription 
factors. Because of similarities at the clinical, 
morphologic, immunohistochemical, and genetic 
levels, the Xp11 translocation RCCs and t(6;11) 
RCCs are currently grouped together under the 
category of MiT family translocation renal cell 
carcinoma. 
Clinics and pathology 
Etiology 
Unclear 
Epidemiology 
Fewer than 10 cases reported in the literature, 
median age is 36 years. 
Pathology 
NONO-TFE3 RCCs frequently have papillary 
architecture and clear cells with subnuclear 
vacuoles.  
Rare Xp11 translocation perivascular epithelioid cell 
tumors (PEComas) harbor the same gene fusion. 
Treatment 
Surgical excision. 
Evolution 
Unknown. 
Cytogenetics 
Cytogenetics Morphological 
inv(X)(p11.2q12). 
Genes involved and 
proteins 
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TFE3 (transcription factor E3) 
Location Xp11.23 
DNA / RNA 
The TFE3 gene includes a 5' untranslated region, 8 
exons, and a 3' untranslated region. 
Protein 
TFE3 is a transcription factor with a basic helix-
loop-helix DNA binding domain and a leucine 
zipper dimerization domain. TFE3 contains a 
nuclear localization signal, encoded at the junction 
of exons 5 and 6, which is retained within all known 
TFE3 fusion proteins.  
TFE3 protein is 575 amino acids, and is ubiquitously 
expressed. TFE3, TFEB, TFEC and MITF comprise 
the members of the microphthalmia transcription 
factor subfamily, which have homologous DNA 
binding domains and in fact bind to a common DNA 
sequence. These four transcription factors may 
homo- or heterodimerize to bind DNA, and they may 
have functional overlap. 
NONO (non-POU domain containing, 
octamer-binding) 
Location Xq13.1 
Protein 
NONO is a 471 amino acid protein with several 
distinctive domains. From N-terminus to C-
terminus, it has : 
1) an N-terminal basic region composed entirely of 
Proline, Glutamine, and Histidine, 
2) a pair of RNA recognition motifs, 
3) a helix-turn helix domain followed by a series of 
charged amino acids that likely forms a DNA-
binding unit, 
4) a short C-terminal Proline-rich region. 
SFPQ and NONO are highly homologous and 
related proteins. NONO has a region of 320 amino 
acids with a 71% identity and a 7% similarity to a 
320 amino acid region within PSF. Both proteins 
have both DNA and RNA binding domains, which 
underlies their multifunctionality. Indeed, these 
proteins have been implicated in both transcriptional 
activation and splicing. Both proteins are known to 
bind to the DNA binding domains of nuclear 
hormone receptors (such as the thyroid hormone 
receptors and the retinoid X receptors), and modulate 
transcriptional activation. These proteins bind to 
each other, select the same optimal RNA sequence 
from RNA pools, and have been associated with 
spliceosomes. Both have been shown to bind to the 
C-terminal domain of RNA polymerase II, where 
they may couple pre-mRNA  
splicing and RNA processing.  
SFPQ and NONO enhance Topoisomerase I 
cleavage of DNA, and induce its jumping to other 
DNA helices after cleavage.  
Finally, both have been shown to bind and retain 
defective and hyperedited mRNAs within the 
nucleus, preventing translation of mutated proteins. 
Result of the chromosomal 
anomaly 
Hybrid Gene 
Description 
5' NONO - 3' TFE3 
Fusion Protein 
Description 
The inv (X)(p11.2q12) results in fusion of virtually 
the entire sequence of NONO/p54nrb with the C-
terminal portion of the TFE transcription factor that 
contains the basic helix-loop-helix (bHLH) DNA 
binding domain and Leucine Zipper domain. 
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